Cargando…

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?

Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic and the most common cause of chronic liver disease worldwide. It consists of a spectrum of liver disorders ranging from simple steatosis to NASH which predisposes patients to further fibrosis, cirrhosis and even hepatocarcinoma. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theys, Claudia, Lauwers, Dorien, Perez-Novo, Claudina, Vanden Berghe, Wim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775974/ https://www.ncbi.nlm.nih.gov/pubmed/36551797 http://dx.doi.org/10.3390/biomedicines10123041

Ejemplares similares

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
por: Issa, Mark E., et al.
Publicado: (2017)

Peptides as epigenetic modulators: therapeutic implications
por: Janssens, Yorick, et al.
Publicado: (2019)

The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
por: Porcuna, Jesús, et al.
Publicado: (2021)

The driver's seat /
por: Spark, Muriel
Publicado: (1974)

Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells
por: Logie, Emilie, et al.
Publicado: (2021)

“HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex”
por: Velastegui, Erick, et al.
Publicado: (2023)

Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences
por: Declerck, Ken, et al.
Publicado: (2021)

Genetic and epigenetic factors determining NAFLD risk
por: Jonas, Wenke, et al.
Publicado: (2020)

From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2015)

Acute myeloid leukemia therapeutics: CARs in the driver’s seat
por: Mardiros, Armen, et al.
Publicado: (2013)

Hypermutation takes the driver’s seat
por: Schlesner, Matthias, et al.
Publicado: (2015)

Editorial: Epigenetic and Transcriptional Dysregulations in Cancer and Therapeutic Opportunities
por: Ansari, Rais A., et al.
Publicado: (2022)

Epigenetic Drivers in Pediatric Medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2017)

Metabolic syndrome: Nutri-epigenetic cause or consequence?
por: Silva-Ochoa, Alfonso D., et al.
Publicado: (2023)

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2017)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
por: Herranz, Jose M., et al.
Publicado: (2023)

Computational biologists: moving to the driver's seat
por: Yanai, Itai, et al.
Publicado: (2017)

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
por: Régnier, Marion, et al.
Publicado: (2020)

Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
por: Canale, Matteo, et al.
Publicado: (2020)

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
por: Tien, Feng-Ming, et al.
Publicado: (2023)

Social Epigenetics and Equality of Opportunity
por: Loi, Michele, et al.
Publicado: (2013)

Epigenetic opportunities for evolutionary computation
por: Yuen, Sizhe, et al.
Publicado: (2023)

Epigenetic and Anesthesia: Challenges and Opportunities
por: Roodneshin, Fatemeh
Publicado: (2023)

Cubilin expression is monoallelic and epigenetically augmented via PPARs
por: Aseem, Obaidullah, et al.
Publicado: (2013)

Contra-lateral shoulder dislocation caused by seat belts in drivers and front-seat passengers
por: Abu-Zidan, Fikri M., et al.
Publicado: (2015)

Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
por: Tian, Yuan, et al.
Publicado: (2016)

Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities
por: Coronel-Hernández, Jossimar, et al.
Publicado: (2021)

Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
por: Alcaraz, Jordi, et al.
Publicado: (2021)

Epigenetic and Transcriptional Signaling in Ewing Sarcoma—Disease Etiology and Therapeutic Opportunities
por: Li, Mingli, et al.
Publicado: (2022)

Bronchopulmonary Dysplasia: Endothelial Cells in the Driver’s Seat
por: Vohwinkel, Christine U., et al.
Publicado: (2021)

The antigen‐binding moiety in the driver's seat of CARs
por: Hanssens, Heleen, et al.
Publicado: (2021)

Identifying New Epigenetic Drivers of Liver Fibrosis
por: Argemi, Josepmaria, et al.
Publicado: (2018)

Epigenetics as Driver of Adaptation and Diversification in Microbial Eukaryotes
por: Weiner, Agnes K. M., et al.
Publicado: (2021)

Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis
por: von Eyben, Finn E., et al.
Publicado: (2023)

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
por: Peyrou, Marion, et al.
Publicado: (2012)

Transcriptional and epigenetic regulation of PPARγ expression during adipogenesis
por: Lee, Ji-Eun, et al.
Publicado: (2014)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

Insights into the Role of PPARβ/δ in NAFLD
por: Chen, Jiapeng, et al.
Publicado: (2018)

PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen
por: Tinsley, Samantha L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_16ovvtliafhlqs3kgt8iknsq7c